Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 USD | -9.98% |
|
-.--% | +29.82% |
Jun. 27 | Hansa Biopharma AB Announces Board Appointments | CI |
May. 31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
- Stock Market
- Equities
- HNSA Stock
- HNSBF Stock
- News Hansa Biopharma AB
- Press Releases